LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma

BACKGROUND: Glioma is characterized by high morbidity, high mortality, and poor prognosis. Despite tremendous advances in the treatment of glioma, the prognosis of patients with glioma is still unsatisfactory. There is an urgent need to discover novel molecular markers that effectively predict progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xuqiang, Chen, Di, Sun, Yiyu, Yang, Shuo, Wang, Weiguang, Liu, Bing, Gao, Peng, Li, Xueyuan, Wu, Lixin, Ma, Siqi, Lin, Wenyang, Ma, Jiwei, Yan, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901081/
https://www.ncbi.nlm.nih.gov/pubmed/36747161
http://dx.doi.org/10.1186/s12885-023-10594-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901081/
https://www.ncbi.nlm.nih.gov/pubmed/36747161
http://dx.doi.org/10.1186/s12885-023-10594-y

Ejemplares similares